1Schuchter LM,Luginbuhl WE,Meropol NJ.The current status of toxicity protectants in cancer therapy[J].Semin Oncol,1992,19(6):742-751. 被引量：1
2Illiano A,Barletta E,De Marino V,et al.New triplet che motherapy combination with carboplatin,paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer:a phase Ⅱ study[J].Anticancer Res,2000,20(5c):3999-4003. 被引量：1
3Wadler S,Haynes H,Beitler JJ,et al.Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy.The New York Gynecologic Oncology Group[J].J Clin Oncol,1993,11(8):1517-1522. 被引量：1
4Kemp G, Rose P, Lurain J, et al. Amifostine pretreatment for pro- tection aganist cyclopho phamide induced and cisplatin induced toxicities results of a randanized control trail in patients with advanced ovarian cancer. J Clin Oncol, 1996,14(9):2101-2112. 被引量：1
